| --- | --- | --- | --- | --- | --- | |-------|-------|--------------------------------------------------------------------|-------|-------|-------| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | J.P. Morgan 2019 Global High Yield & Leveraged Finance Conference | | | | | | | Executive Vice President and Chief Financial Officer, MEDNAX, Inc. | | | | | | | | | | | 1 Forward looking disclosure 1 Certain statements and information in this presentation may be deemed to ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number 001-12111 MEDNAX, INC. (Exact name of registrant as specified in its charter) FLORIDA 26-3667538 (State or other jurisdiction of inco ...

Mednax, Inc. (NYSE:MD) Q4 2018 Earnings Conference Call February 7, 2019 10:00 AM ET Company Participants Charles Lynch - Vice President Strategy and Investor Relations Roger Medel - CEO Stephen Farber - CFO Conference Call Participants Ralph Giacobbe - Citigroup Jason Plagman - Jefferies A.J. Rice - Credit Suisse Kevin Fischbeck - Bank of America Ana Gupte - SVB Leerink Gary Taylor - JPMorgan John Ransom - Raymond James Pito Chickering - Deutsche Bank Operator Ladies and gentlemen, thank you for standing b ...